StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...

UW Medicine is unveiling an FDA-approved spinal cord therapy in an effort to offer new hope for paralyzed patients.

Analyst Price Forecast Suggests 35.56% Upside As of December 23, 2024, the average one-year price target for Orthofix Medical is $24.89/share. The forecasts range from a low of $22.22 to a high of ...

Comparatively, Orthofix Medical ... and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as ...

Summary: Researchers are making strides in restoring touch sensations to prosthetic limbs through brain stimulation. By using electrodes ... of ICMS-evoked percepts in three participants with cervical ...

Roughly two women in Britain every day die from cervical cancer, which famously killed TV personality Jade Goody at the age of just 27. The disease is often called a 'silent killer' because its ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A new approach to treating cervical cancer could help people with locally advanced cervical cancer live longer. This includes cancers that have spread beyond the cervix, but have not yet spread to ...

"Three minutes is like doing 200 push-ups," he claims. Loading YouTube content This technology, called electrical muscle stimulation or EMS, was explored by the Russians back in the 1960s to help ...